Neoadjuvant chemotherapy plus anlotinib in the treatment of resectable head and neck squamous cell carcinoma: A pilot phase II trial

Authors

Institutions

Publication Details

Journal
Cancer Communications
Published
2025-02-19
DOI
https://doi.org/10.1002/cac2.70006
Primary Topic
Head and Neck Cancer Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Neoadjuvant chemotherapy plus anlotinib in the treatment of resectable head and neck squamous cell carcinoma: A pilot phase II trial

Dongxiao Tang, Demeng Chen, Shuojin Huang, Congyuan Cao et al.
Cancer Communications
Head and Neck Cancer Studies
article

Neoadjuvant chemotherapy plus anlotinib in the treatment of resectable head and neck squamous cell carcinoma: A pilot phase II trial

Dongxiao Tang, Demeng Chen, Shuojin Huang, Congyuan Cao, Rongsong Ling, Anxun Wang, Wanhang Zhou, Yanchen Li, Qianting He, Jie Chen, Xin Zheng, Bokai Yun
article en

Abstract

No abstract available for this paper.
Cancer CommunicationsVol. 45(5)
Sun Yat-sen University (CN), The First Affiliated Hospital, Sun Yat-sen University (CN), Stomatology Hospital (CN), Third Affiliated Hospital of Sun Yat-sen University (CN), Tang Hospital (CN)
National Natural Science Foundation of China, China Postdoctoral Science Foundation, Natural Science Foundation of Guangdong Province, Guangzhou Municipal Science and Technology Bureau, Basic and Applied Basic Research Foundation of Guangdong Province
Good health and well-being
Openalex Percentile: Top 96%
Head and Neck Cancer Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Neoadjuvant chemotherapy plus anlotinib in the treatment of resectable head and neck squamous cell carcinoma: A pilot phase II trial — Dongxiao Tang, Demeng Chen, et al. · Cancer Communications (2025) | TGRS Research Map | TGRS